Rocephin Generics Ship After Roche’s Ceftriaxone Patent Expires
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche is forecasting a "classic erosion" of its injectable antibiotic Rocephin (ceftriaxone) after patent protection expired July 19